Last year in Autumn we had this buyout rumor. I remember back then Exact Sciences said to approach Invitae about a potential merger.
Now, NVTA, Invitae Corporation, is trading at an all-time low, $0.62.
Some deals take one or two years to perfect, and we don't know what caused the recent price decrease.
Sometimes this happens before an announcement.
Today,...
BNTC Benitec Biopharma Inc is a development-stage biotechnology company which focuses on the development of novel genetic medicines.
The company develops DNA-directed RNA interference based therapeutics.
BlackRock Inc., Renaissance Technologies LLC, Vanguard Group Inc. and Morgan Stanley have stakes in it.
On 2/17/2022 P. Trucchio from HC Wainwright brokerage...
Yesterday, JMP Securities Initiated Coverage on Quoin Pharmaceuticals, Ltd. (QNRX) with a Market Outperform rating and a price target of 8usd.
Quoin Pharmaceuticals (NASDAQ: QNRX) is positioned to deliver the first FDA-approved treatment for Netherton Syndrome, a devastating disorder which affects 1 in every 200,000 people worldwide.
This month, QNRX Signed...
Morgan Stanley disclosed in an SEC filing that it had increased its stake in the company by around 5.2%!
Don`t worry, it has still upside potential, despite the 130% increase in the Pre-Market.
Market Cap of only 15.37M
This is a 5X stock, Not trading advice as you know! :)
This was a private call from my trading group and one of my top picks for March.
You...
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy...
